Ohio State hematologist Dr. Kerry Rogers says chemotherapy and newer targeted drugs both work well, and the right choice depends on the patient.
|Articles|December 7, 2018
The Basics of Interventional Clinical Trials
Author(s)William P. Harris, M.D.
An expert describes what an interventional clinical trial is.
Advertisement
William P. Harris, M.D., associate professor of Medical Oncology at the University of Washington Medical Center and associate member of the Clinical Research Division of the Fred Hutchinson Cancer Center, explains the basics of clinical trials.
Harris mainly works in interventional clinical trials, which compare a new drug or treatment (such as surgery or radiation) to current standard of care to see which one produces better outcomes.
Advertisement
Related to this article
Gita Kwatra, PharmD, MBA, co-founder and CEO of the Glioblastoma Foundation, explains what happens to tumor tissue after brain surgery and how patients can ask their care team for genomic testing.
A breast surgeon explains why patients should raise lymphedema with their care team at the start of treatment, and how early detection can make it reversible.
A woman with stage 4 pancreatic cancer shares how a once-daily RAS inhibitor changed her energy, routine and time with family.
Brad Dugai and Russ Reed discuss symptom relief, skin-related side effects and challenges accessing Rasonque, a treatment for pancreatic cancer.
A nurse practitioner discusses how an app provides information on cancer treatments, potential side effects and preparing for medical appointments.
Final KEYNOTE-564 data show Keytruda after kidney cancer surgery lowered the risk of death by 30%. Dr. Toni Choueiri explains what it means for patients.
A physician emphasized how emotional support, reliable health information and caregiver involvement can encourage men to take a more proactive approach to prostate cancer screening and care.
Advertisement
Advertisement